MedPath

海南通用三洋药业有限公司

Ownership
-
Established
2001-08-20
Employees
-
Market Cap
-
Website
http://www.gener-sanyang.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

135

NMPA:135

Drug Approvals

Tedizolid Phosphate Tablets

Product Name
磷酸特地唑胺片
Approval Number
国药准字H20254436
Approval Date
Jun 3, 2025
NMPA

Cefotiam Hydrochloride for Injection

Product Name
注射用盐酸头孢替安
Approval Number
国药准字H20193388
Approval Date
Oct 16, 2024
NMPA

Cefotiam Hydrochloride for Injection

Product Name
注射用盐酸头孢替安
Approval Number
国药准字H20193389
Approval Date
Oct 16, 2024
NMPA

Cefotiam Hydrochloride for Injection

Product Name
注射用盐酸头孢替安
Approval Number
国药准字H20193390
Approval Date
Oct 16, 2024
NMPA

Rosuvastatin Calcium Capsules

Product Name
瑞舒伐他汀钙胶囊
Approval Number
国药准字H20140135
Approval Date
Oct 9, 2024
NMPA

Rosuvastatin Calcium Capsules

Product Name
瑞舒伐他汀钙胶囊
Approval Number
国药准字H20140136
Approval Date
Oct 9, 2024
NMPA

Cefuroxime Sodium for Injection

Product Name
注射用头孢呋辛钠
Approval Number
国药准字H20247180
Approval Date
Aug 1, 2024
NMPA

Cefuroxime Sodium for Injection

Product Name
注射用头孢呋辛钠
Approval Number
国药准字H20247181
Approval Date
Aug 1, 2024
NMPA

Cefuroxime Sodium for Injection

Product Name
注射用头孢呋辛钠
Approval Number
国药准字H20247178
Approval Date
Aug 1, 2024
NMPA

Cefpiramide Sodium for Injection

Product Name
注射用头孢匹胺钠
Approval Number
国药准字H20063597
Approval Date
Jul 30, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.